ELV insider buying – Elevance Health, Inc.

5 insider purchases since 2016 worth $5.1M by 4 different insiders. Last 12 months: 3 purchases, $2.2M. Most recent filing: 2026-07-17.

Large company Public float $87.3B (latest 10-K, SEC).

Where insiders bought and sold ELV – last 5 yearsCEO / officers Directors Funds & 10% owners Sales

Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.

Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.

Bought, sold, still holding?

InsiderBoughtFirst / last buySold since 2016Holds now*Status
BOUDREAUX GAIL
CEO
$3.4M
2× · 11,225 sh
2025-07-18
2026-07-17
1× · $17.0M
last 2024-07-22
172,036 shares
as of 2026-07-17
Holds (sold earlier)
COLLIS STEVEN H
Director
$869,520
1× · 3,000 sh
2026-03-05
2026-03-05
–4,202 shares
as of 2026-05-15
Holds - never sold
DeVore Susan D.
Director
$374,580
1× · 1,200 sh
2025-08-19
2025-08-19
–4,065 shares
as of 2026-05-15
Holds - never sold
PERU RAMIRO G
Director
$366,050
1× · 1,000 sh
2026-07-17
2026-07-17
2× · $776,735
last 2024-08-05
10,908 shares
as of 2026-07-17
Holds (sold earlier)

* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.

Insider buying and selling by year

YearPurchasesBoughtBuyersSalesSold
20263$2.2M34$1.7M
20252$2.8M23$3.5M
20240––9$44.2M
20230––5$11.1M

Insider purchases

FiledInsiderRoleSharesAvg priceValueHoldingsFiling
2026-07-17PERU RAMIRO GDirector1,000$366.05$366,050+10.1%SEC
2026-07-17BOUDREAUX GAILCEO2,725$367.79$1.0M+1.6%SEC
2026-03-06COLLIS STEVEN HDirector3,000$289.84$869,520+469.5%SEC
2025-08-21DeVore Susan D.Director1,200$312.15$374,580+52.1%SEC
2025-07-18BOUDREAUX GAILCEO8,500$286.94$2.4M+6.0%SEC

Insider sales

FiledInsiderRoleSharesAvg priceValueTypeFiling
2026-06-15Penczek Ronald WOfficer369$403.16$148,766SaleSEC
2026-06-12Dixon Robert L JRDirector151$401.77$60,667SaleSEC
2026-05-20Penczek Ronald WOfficer1,531$403.13$617,192SaleSEC
2026-03-09Kendrick Charles Morgan JRCEO3,196$284.92$910,604SaleSEC
2025-04-25Kaye MarkCFO4,588$424.82$1.9MSaleSEC
2025-03-11Penczek Ronald WOfficer443$415.13$183,903SaleSEC
2025-03-05Kendrick Charles Morgan JRCEO3,504$396.30$1.4MSaleSEC
2024-10-18Kendrick Charles Morgan JRCEO7,417$432.14$3.2MSaleSEC
2024-08-06PERU RAMIRO GDirector753$531.52$400,235Pre-planned (10b5-1)SEC
2024-07-23BOUDREAUX GAILCEO34,000$500.98$17.0MPre-planned (10b5-1)SEC
2024-07-22Dixon Robert L JRDirector305$506.76$154,562SaleSEC
2024-04-25Norwood Felicia FCEO20,310$533.34$10.8MSaleSEC
2024-03-12Kendrick Charles Morgan JRCEO2,432$500.46$1.2MSaleSEC
2024-03-08Penczek Ronald WOfficer916$504.58$462,195SaleSEC
2024-03-05Haytaian Peter DOfficer21,095$500.18$10.6MPre-planned (10b5-1)SEC

Showing the latest 15 of 21 sales of $50,000+ since 2016.

Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.

Get every new insider purchase the day it's filed

Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.

Get started free